BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26885977)

  • 1. The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa.
    Long LC; Fox MP; Sauls C; Evans D; Sanne I; Rosen SB
    PLoS One; 2016; 11(2):e0148546. PubMed ID: 26885977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
    Fleishman JA; Gebo KA; Reilly ED; Conviser R; Christopher Mathews W; Todd Korthuis P; Hellinger J; Rutstein R; Keiser P; Rubin H; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III40-52. PubMed ID: 16116308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa.
    Meyer-Rath G; Miners A; Santos AC; Variava E; Venter WD
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e25-32. PubMed ID: 22895437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early severe morbidity and resource utilization in South African adults on antiretroviral therapy.
    de Cherif TK; Schoeman JH; Cleary S; Meintjes GA; Rebe K; Maartens G
    BMC Infect Dis; 2009 Dec; 9():205. PubMed ID: 20003472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated morbidity and mortality in a setting of high ART coverage: prospective surveillance results from a district hospital in Botswana.
    Barak T; Neo DT; Tapela N; Mophuthegi P; Zash R; Kalenga K; Perry ME; Malane M; Makhema J; Lockman S; Shapiro R
    J Int AIDS Soc; 2019 Dec; 22(12):e25428. PubMed ID: 31850683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lifetime cost of current human immunodeficiency virus care in the United States.
    Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
    Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
    Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
    Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi.
    Maheswaran H; Petrou S; Cohen D; MacPherson P; Kumwenda F; Lalloo DG; Corbett EL; Clarke A
    PLoS One; 2018; 13(3):e0192991. PubMed ID: 29543818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of implementing universal test and treat in three correctional facilities in South Africa and Zambia.
    Mukora R; Smith HJ; Herce ME; Chimoyi L; Hausler H; Fielding KL; Charalambous S; Hoffmann CJ
    PLoS One; 2022; 17(8):e0272595. PubMed ID: 36006967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital).
    Kevany S; Meintjes G; Rebe K; Maartens G; Cleary S
    S Afr Med J; 2009 May; 99(5):320-5. PubMed ID: 19588792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some effects of the rising case load of adult HIV-related disease on a hospital in Nairobi.
    Gilks CF; Floyd K; Otieno LS; Adam AM; Bhatt SM; Warrell DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):234-40. PubMed ID: 9665500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV disease burden, cost, and length of stay in Portuguese hospitals from 2000 to 2010: a cross-sectional study.
    Catumbela E; Freitas A; Lopes F; Mendoza Mdel C; Costa C; Sarmento A; da Costa-Pereira A
    BMC Health Serv Res; 2015 Apr; 15():144. PubMed ID: 25889920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis.
    Meyer-Rath G; Pienaar J; Brink B; van Zyl A; Muirhead D; Grant A; Churchyard G; Watts C; Vickerman P
    PLoS Med; 2015 Sep; 12(9):e1001869. PubMed ID: 26327271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of highly active antiretroviral therapy in South Africa.
    Badri M; Maartens G; Mandalia S; Bekker LG; Penrod JR; Platt RW; Wood R; Beck EJ
    PLoS Med; 2006 Jan; 3(1):e4. PubMed ID: 16318413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
    Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
    PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.
    Long LC; Rosen SB; Brennan A; Moyo F; Sauls C; Evans D; Modi SL; Sanne I; Fox MP
    PLoS One; 2016; 11(12):e0168118. PubMed ID: 27942005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of HIV medical care in the era of highly active antiretroviral therapy.
    Gebo KA; Chaisson RE; Folkemer JG; Bartlett JG; Moore RD
    AIDS; 1999 May; 13(8):963-9. PubMed ID: 10371178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "My future is bright…I won't die with the cause of AIDS": ten-year patient ART outcomes and experiences in South Africa.
    Hendrickson CJ; Pascoe SJS; Huber AN; Moolla A; Maskew M; Long LC; Fox MP
    J Int AIDS Soc; 2018 Oct; 21(10):e25184. PubMed ID: 30318848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.